POSTER PROCEEDINGS

Bedia Çakmakoğlu

EN

POSTER PROCEEDINGS

Abstract

Omics Technologies in Life Sciences: From Genome to Therapy Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye

Keywords

References

1. Bowman P, Flanagan SE, Edghill EL, Damhuis A, Shepherd MH, Paisey R, et. al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia. 2012 Jan;55(1):123-7.
2. Qin LJ, Lv Y, Huang QY. Meta-analysis of association of common variants in the KCNJ11-ABCC8region with type 2 diabetes. Genet Mol Res 12.3 (2013): 2990-3002.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Authors

Bedia Çakmakoğlu ^*
Türkiye

Publication Date

April 18, 2022

Submission Date

April 18, 2022

Acceptance Date

April 18, 2022

Published in Issue

Year 2022 Volume: 12 Number: Supplement 1

IZ

https://izlik.org/JA38AF69BJ

Cite

RIS / Bibtex

APA

Çakmakoğlu, B. (2022). POSTER PROCEEDINGS. Experimed, 12(Supplement 1), 23-25. https://izlik.org/JA38AF69BJ

AMA

1.Çakmakoğlu B. POSTER PROCEEDINGS. Experimed. 2022;12(Supplement 1):23-25. https://izlik.org/JA38AF69BJ

Chicago

Çakmakoğlu, Bedia. 2022. “POSTER PROCEEDINGS”. Experimed 12 (Supplement 1): 23-25. https://izlik.org/JA38AF69BJ.

EndNote

Çakmakoğlu B (April 1, 2022) POSTER PROCEEDINGS. Experimed 12 Supplement 1 23–25.

IEEE

[1]B. Çakmakoğlu, “POSTER PROCEEDINGS”, Experimed, vol. 12, no. Supplement 1, pp. 23–25, Apr. 2022, [Online]. Available: https://izlik.org/JA38AF69BJ

ISNAD

Çakmakoğlu, Bedia. “POSTER PROCEEDINGS”. Experimed 12/Supplement 1 (April 1, 2022): 23-25. https://izlik.org/JA38AF69BJ.

JAMA

1.Çakmakoğlu B. POSTER PROCEEDINGS. Experimed. 2022;12:23–25.

MLA

Çakmakoğlu, Bedia. “POSTER PROCEEDINGS”. Experimed, vol. 12, no. Supplement 1, Apr. 2022, pp. 23-25, https://izlik.org/JA38AF69BJ.

Vancouver

1.Bedia Çakmakoğlu. POSTER PROCEEDINGS. Experimed [Internet]. 2022 Apr. 1;12(Supplement 1):23-5. Available from: https://izlik.org/JA38AF69BJ